Pfizer targets early June to submit COVID vaccine data on youngest kids

Österreich Nachrichten Nachrichten

Pfizer targets early June to submit COVID vaccine data on youngest kids
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 njdotcom
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

Only children ages 5 or older can be vaccinated in the U.S.

The Associated Press

Pfizer hopes to tell U.S. regulators how well its COVID-19 vaccine works in the youngest kids by late May or early June. The drugmaker is testing three extra-small doses of its vaccine in children under 5 after two shots didn’t prove quite strong enough. Initial results had been expected last month but the company laid out the latest timeline Tuesday during its discussion of quarterlyCurrently in the U.S., only children ages 5 or older can be vaccinated, using Pfizer’s vaccine — leaving 18 million younger tots unprotected..

Note to readers: if you purchase something through one of our affiliate links we may earn a commission.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

njdotcom /  🏆 282. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer Inc. undefined posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The...
Weiterlesen »

Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesPfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Weiterlesen »

Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Weiterlesen »

Pfizer hopes to submit little-kid vaccine data by early JunePfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June
Weiterlesen »

Pfizer hopes to submit little-kid vaccine data by early JunePfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June.
Weiterlesen »

Pfizer Hopes to Submit Little-Kid Vaccine Data by Early JunePfizer Hopes to Submit Little-Kid Vaccine Data by Early JunePfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
Weiterlesen »



Render Time: 2025-04-25 23:34:55